Hansenula-Derived Pegylated-Interferon Alpha-2a in Egyptian Children With Chronic HCV

Clinical trial NCT02027493 · COMPLETED

Trial details

NCT number: NCT02027493
Sponsor: National Liver Institute, Egypt
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2009-02-01
Primary completion: 2011-01-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.